J0833 – Injection, cosyntropin, not otherwise specified, 0.25 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0833
- Long description
- Injection, cosyntropin, not otherwise specified, 0.25 mg
- Short description
- Cosyntropin injection nos
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2010
- Last change
- January 1, 2019 – No change
- Termination date
- December 31, 2018
Frequently asked questions
What is HCPCS code J0833?
J0833 is a HCPCS Level II code for injection, cosyntropin, not otherwise specified, 0.25 mg. It was discontinued on December 31, 2018.
Does Medicare cover J0833?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0775 – Injection, collagenase, clostridium histolyticum, 0.01 mg
- J0780 – Injection, prochlorperazine, up to 10 mg
- J0791 – Injection, crizanlizumab-tmca, 5 mg
- J0795 – Injection, corticorelin ovine triflutate, 1 microgram
- J0799 – Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
- J0800 – Injection, corticotropin, up to 40 units
- J0801 – Injection, corticotropin (acthar gel), up to 40 units
- J0802 – Injection, corticotropin (ani), up to 40 units
- J0834 – Injection, cosyntropin, 0.25 mg
- J0840 – Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841 – Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850 – Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870 – Injection, imetelstat, 1 mg
- J0871 – Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg
- J0872 – Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0873 – Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.